DaVita, Fresenius slide on Trump threat to overhaul dialysis market

Shares of dialysis providers DaVita Healthcare (NYSE:DVA) and Fresenius (NYSE:FMS) took a hit today after a report surfaced that the Trump administration is readying an overhaul of the kidney treatment market. The president plans to issue an executive order tomorrow that would seek to incentivize kidney transplants and home hemodialysis in a bid to lower the federal government’s annual $100 billion kidney care tab, Politico reported, citing “two individuals with knowledge of the announcement.” The strategy involves new payment models from the U.S. Health &Human Services Dept. designed to move patients out of brick-and-mortar dialysis clinics and into their own homes for treatment, according to “four individuals familiar with the plan” quoted by the website. HHS also plans to increase prevention and screening for kidney disease. HHS said it couldn’t comment on potential rulemaking. The White House did not respond to requests for comment, Politico reported. The news sent shares of DaVita and Fresenius, which dominate the hemodialysis clinic market, down significantly today. DVA shares were off -7.4% to $51.40; FMS shares slid -5.5% to $37.28, both in early afternoon trading. “Two companies effectively control the market and neither currently are financially incentivized to change behavior,” Raymond James analyst and former HHS official Chris Meekins told Politico. “The administration needs to put forward enough carr...
Source: Mass Device - Category: Medical Devices Authors: Tags: Dialysis Featured Wall Street Beat DaVita Inc. Dept. of Health & Human Services (HHS) Fresenius Source Type: news

Related Links:

This study aimed to identify the access to these resources on a global scale using data from the multinational survey conducted by the International Society of Nephrology (ISN) (Global Kidney Health Atlas (GKHA) project), with emphasis on developing nations. For data analysis, the 125 participating countries were sorted into the 4 World Bank income groups: low income (LIC), lower-middle income (LMIC), upper-middle income (UMIC), and high income (HIC). A severe shortage of nephrologists was observed in LIC and LMIC with
Source: Clinical Nephrology - Category: Urology & Nephrology Authors: Tags: Clin Nephrol Source Type: research
Abstract Chronic kidney disease (CKD) particularly in its most severe form, end-stage renal disease (ESRD), is highly prevalent globally. Although both the incidence and prevalence appears to be increasing, the rate of increase is far higher in developing countries, probably as a result of underdevelopment, high incidence of communicable and noncommunicable diseases, poverty as well as inaccessible, unavailable, or unaffordable treatment modalities. The epidemiology differs remarkably between developing and developed economies - it afflicts the young and middle-aged in the former and older individuals in the latte...
Source: Clinical Nephrology - Category: Urology & Nephrology Authors: Tags: Clin Nephrol Source Type: research
Unilateral or bilateral approach for nephrectomy in horseshoe kidney by minimally invasive surgery has been described. A total binephrectomy by a unilateral retroperitoneoscopic approach was performed for congenital nephrotic syndrome.A unilateral retroperitoneoscopic approach was planned in a 3-year-old boy (13 kg) with a congenital nephrotic syndrome resistant to steroids with massive protein loss.Operative time was 160 minutes. Postoperative course was uneventful with continued hemodialysis until renal transplant 18 months later.
Source: Journal of Pediatric Urology - Category: Urology & Nephrology Authors: Tags: Video Bank Source Type: research
Authors: Robles-Osorio ML, Corona R, Morales T, Sabath E Abstract Alterations in the sense of smell (dysosmia, anosmia, hyposmia) are frequently experienced by patients with chronic kidney disease. However, currently, the aetiology and consequences are poorly understood, with no effective treatments available to address such impairment. In general, the capacity of olfactory perception is affected in patients with chronic kidney disease (even in those who have not undergone dialysis therapy), and whether these alterations improve after dialysis is disputed. Patients in peritoneal dialysis and haemodialysis have the ...
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
The rising prevalence of obesity is a well known global problem, as is the relationship between obesity and end stage renal disease (ESRD). Even though the best treatment for ESRD is kidney transplantation, haemodialysis, which depends on vascular access, is a key element in the management of ESRD. The first line haemodialysis option with the best short and long term results is the creation of native arteriovenous access (arteriovenous fistula, AVF). Unfortunately, obese patients with ESRD are higher risk of unsuccessful AVF creation due to maturation problems associated with deep veins.
Source: European Journal of Vascular and Endovascular Surgery - Category: Surgery Authors: Tags: Invited Commentary Source Type: research
Hepatitis C viral (HCV) infection is a global health problem with significant health and economic burden, which can lead to chronic kidney disease (CKD) and affect multiple organ systems. In addition, prevalence of hepatitis C remains higher in patients with CKD, including those on chronic hemodialysis and in individuals with a kidney transplant than in the general population. There has been a dramatic shift in the management of hepatitis C since Kidney Disease: Improving Global Outcome (KDIGO) published its 2008 guideline for the prevention, diagnosis and management of hepatitis C in CKD.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: research
ConclusionIn DT1 patients, renal transplantation is the best treatment for ESRD despite the use of corticosteroids and anticalcineurins. However, prior explorations of good cardiac function and adequate vascular compliance are essential to reduce the risk of CV.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
A 55-year-old man with a history of end-stage renal disease due to autosomal dominant polycystic kidney disease and bilateral nephrectomy without adrenalectomy underwent his first kidney transplantation after 6 years of hemodialysis. The patient had no history of donor-specific antibodies. The donor was described as a 69-year-old man with a history of active smoking and  aortic valvulopathy who died of a stroke without cardiac arrest or collapse. Maintenance immunosuppressive therapy consisted of low-dose tacrolimus and everolimus.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Make Your Diagnosis Source Type: research
CONCLUSIONS Peritoneal dialysis is not a risk factor for postoperative complications after SPKT. PMID: 31320604 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Tags: Ann Transplant Source Type: research
BACKGROUND: Dialysis is the first procedure to partially replace renal function in end-stage renal diseases, despite several adverse side effects, such as infections. The primary aim of this study was to evaluate the levels of immune CMV-specific CD8+ T cells in a representative cohort of pre-transplant patients receiving hemodialysis (HD) or peritoneal dialysis (PD). The secondary aim was to monitor the CMV-specific CD8+ T cells in kidney transplant recipients undergoing different types of dialysis during the first year following their transplant. METHODS: 69 patients were enrolled and examined with respect to the type o...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: American Health | Carrots | Dialysis | Government | Hemodialysis | Kidney Transplant | Kidney Transplantation | Medical Devices | Politics | Transplant Surgery | Transplants | Trump | Urology & Nephrology | USA Health | Websites